Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

M. Burotto; J. Wilkerson; W. Stein; R. Motzer; S. Bates

doi:10.1371/journal.pone.0105179

Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

M. Burotto, J. Wilkerson, W. Stein, R. Motzer, S. Bates

Clínica Universidad de los Andes

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	e105179
Journal	PLoS ONE
Volume	9
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0105179
State	Published - 31 Jul 2014

Keywords

erratum
error

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0105179

Cite this

@article{5c4e36be6fd74df7913c88944d9f00b4,

title = "Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)",

keywords = "erratum, error",

author = "M. Burotto and J. Wilkerson and W. Stein and R. Motzer and S. Bates",

year = "2014",

month = jul,

day = "31",

doi = "10.1371/journal.pone.0105179",

language = "English",

volume = "9",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "7",

}

TY - JOUR

T1 - Correction

T2 - Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

AU - Burotto, M.

AU - Wilkerson, J.

AU - Stein, W.

AU - Motzer, R.

AU - Bates, S.

PY - 2014/7/31

Y1 - 2014/7/31

KW - erratum

KW - error

UR - http://www.scopus.com/inward/record.url?scp=84905281774&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0105179

DO - 10.1371/journal.pone.0105179

M3 - Comment/debate

AN - SCOPUS:84905281774

SN - 1932-6203

VL - 9

JO - PLoS ONE

JF - PLoS ONE

IS - 7

M1 - e105179

ER -

Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

Keywords

UN SDGs

Access to Document

Other files and links

Cite this